Drugs / CholeraGarde®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00741637 | Jul 2010 → Apr 2011 | cholera, diarrheal disease | International Vaccine Institute | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CholeraGarde | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00741637 ↗ |
| Known as | Peru-15 | “Peru-15 (CholeraGarde®) vaccine” NCT00741637 ↗ |
| Modality | Vaccine | “Live attenuated oral Cholera vaccine” NCT00741637 ↗ |
| Route | Oral | “Live attenuated oral Cholera vaccine” NCT00741637 ↗ |